NCT07555860 2026-04-29Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 2 Not yet recruiting28 enrolled